Making Inroads in Cancer Research

Coming to Boston from China, healthcare entrepreneur George Wu, MD, PhD, saw his adopted city as a mecca for medicine. Drawn to the innovative culture of Boston’s Longwood Medical Area, he considered it the perfect environment to launch his company, Massachusetts Medical International, which connects international patients to expert care at neighboring healthcare institutions like Brigham and Women’s Hospital.

One of the most personally rewarding aspects of Wu’s business has been the opportunity to meet compatriots who are passionately pursuing cures for the world’s most challenging diseases. At a gathering for Chinese visiting scholars, he met BWH pathologist Christine Lian, MD. Inspired by Lian’s dermatopathology research of new treatments for melanoma and other skin cancers, Wu invested $100,000 in her program.

“Dr. Wu believes Dr. Lian’s contributions will change the landscape of cancer care,” says Philip Chong, chief operating officer of Massachusetts Medical International. “He sees her lab is making inroads in cancer research and genomic sequencing, which fits with his vision to help patients with cancer around the world.”

Chong says Wu’s gift also builds a bridge between his old and new communities.

“Giving back to the Boston community ultimately means lifting patients all around the world,” says Chong. “We appreciate this opportunity to work with innovators like Dr. Lian, and hospitals like the Brigham that are committed to humanity and global change.”